Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Quidel Sofia 2 Flu+SARS Antigen FIA (25T)
Uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. Allows for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
Manufacturer: Quidel 20377
Description
- One Sample - Three Results
- Results in 15 minutes
- Dual Work Modes
- Virena Connection
- All necessary components included in kit
- Self-contained Test cassette
- For use with Sofia 2
- FDA Emergency Use Authorization.
Specifications
| No | |
| CLIA-Waived* (EUA) | |
| Influenza A+B and COVID-19/2019-nCOV | |
| Immunofluorescence-based lateral flow technology | |
| 12 kits/case | |
| Direct: Nasal Swab, Nasopharyngael Swab | |
| 12 months from date of manufacture | |
| 15°C to 35°C | |
| 15 minutes |
| End-User Placement Agreement Required | |
| Included and available for purchase | |
| Sofia 2 | |
| 25 | |
| Yes | |
| Influenza A: NS - 90%, NPS - 97.1% Influenza B: NS - 89%, NPS - 90% SARS-CoV-2: 95.2% | |
| Influenza A: NS - 95%, NPS - 94.6% Influenza B: NS - 96%, NPS - 97% SARS-CoV-2: 100% | |
| Instrument Read - advanced immunofluorescence-based lateral flow | |
| Rapid Testing |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title